Daniel Wendling Selected Research

Infliximab (Remicade)

12/2014	Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.
1/2012	Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
1/2012	Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis.
12/2011	New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases.
6/2011	Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study.
7/2009	[Spondylarthropathy with Behçet's disease: response to infliximab].
1/2009	Management of ankylosing spondylitis with infliximab.
1/2008	Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
12/2007	Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis.
9/2007	The use of TNF-alpha blocking agents in rheumatoid arthritis: an update.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Wendling Research Topics

Disease

77	Rheumatoid Arthritis 12/2023 - 02/2002
42	Ankylosing Spondylitis 10/2023 - 07/2004
36	Inflammation (Inflammations) 01/2023 - 07/2006
33	Arthritis (Polyarthritis) 04/2022 - 03/2004
22	Axial Spondyloarthritis 02/2024 - 03/2012
18	Infections 12/2023 - 11/2002
14	Spondylarthropathies 10/2016 - 10/2003
12	Rheumatic Diseases (Rheumatism) 12/2023 - 02/2007
12	Pain (Aches) 01/2022 - 05/2011
10	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2008
9	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 03/2024 - 03/2018
9	Joint Diseases (Joint Disease) 01/2019 - 01/2007
8	Uveitis 01/2020 - 12/2011
7	Necrosis 01/2023 - 01/2005
7	Osteoarthritis 01/2021 - 01/2007
6	Sacroiliitis 10/2023 - 07/2013
6	Neoplasms (Cancer) 01/2023 - 09/2007
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2012
6	Psoriatic Arthritis 09/2021 - 04/2006
6	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2015 - 02/2007
4	Back Pain (Backache) 01/2021 - 07/2012
4	Osteoporosis 01/2020 - 01/2010
4	Spondylarthritis (Spinal Arthritis) 01/2020 - 05/2010
3	Dysbiosis 01/2023 - 10/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2020
3	Crohn Disease (Crohn's Disease) 01/2020 - 10/2003
3	Infectious Arthritis (Septic Arthritis) 08/2019 - 03/2008
3	Rheumatic Fever (Acute Articular Rheumatism) 08/2019 - 01/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2009
3	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 12/2017 - 06/2012
3	Lymphoma (Lymphomas) 10/2011 - 09/2007
3	Virus Diseases (Viral Diseases) 09/2010 - 10/2007
3	Tuberculosis (Tuberculoses) 09/2007 - 10/2003
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2020
2	COVID-19 01/2023 - 10/2020
2	Phenylketonurias (Phenylketonuria) 04/2022 - 01/2020
2	Synovitis 01/2022 - 11/2016
2	Edema (Dropsy) 01/2022 - 01/2017
2	Fatigue 01/2022 - 07/2012
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Skin Neoplasms (Skin Cancer) 01/2020 - 01/2015
2	Sepsis (Septicemia) 08/2019 - 03/2010
2	Gout 08/2019 - 02/2015

Drug/Important Bio-Agent (IBA)

35	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 10/2003
21	tocilizumab (atlizumab)FDA Link 03/2024 - 06/2010
18	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 07/2006
16	C-Reactive ProteinIBA 03/2024 - 07/2006
15	Etanercept (Enbrel)FDA Link 01/2019 - 07/2004
15	Infliximab (Remicade)FDA Link 12/2014 - 10/2003
13	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2023 - 01/2005
13	CytokinesIBA 04/2022 - 03/2004
12	Antirheumatic Agents (DMARD)IBA 12/2023 - 01/2007
12	Interleukin-17 (Interleukin 17)IBA 01/2023 - 05/2007
11	GlucocorticoidsIBA 03/2024 - 07/2006
11	Tumor Necrosis Factor InhibitorsIBA 05/2020 - 12/2006
10	Rituximab (Mabthera)FDA Link 12/2023 - 07/2008
7	HLA-B27 Antigen (HLA B27 Antigen)IBA 02/2024 - 04/2011
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2010
7	Biomarkers (Surrogate Marker)IBA 08/2019 - 07/2007
6	Interleukin-23 (Interleukin 23)IBA 09/2023 - 09/2010
6	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023 - 05/2011
6	Abatacept (Orencia)FDA Link 01/2022 - 05/2009
6	Sirtuin 1IBA 01/2021 - 07/2013
6	AdipokinesIBA 01/2021 - 01/2007
6	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 10/2008
5	secukinumabIBA 02/2024 - 12/2017
5	AdiponectinIBA 01/2021 - 01/2007
5	AntibodiesIBA 11/2016 - 12/2006
4	CholesterolIBA 04/2022 - 07/2006
4	ArginaseIBA 04/2022 - 08/2011
4	Prednisone (Sone)FDA LinkGeneric 01/2022 - 03/2018
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 09/2010
4	LeptinIBA 01/2021 - 01/2007
4	Monoclonal AntibodiesIBA 01/2019 - 07/2004
4	Adalimumab (Humira)FDA Link 01/2016 - 12/2011
4	Pamidronate (Aredia)FDA LinkGeneric 10/2014 - 01/2005
3	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2022 - 01/2020
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 03/2012
3	ametantrone (HAQ)IBA 01/2022 - 01/2017
3	Analgesics (Analgesic Drugs)IBA 01/2021 - 07/2012
3	ResistinIBA 01/2021 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2007
3	Histone Deacetylase InhibitorsIBA 01/2013 - 09/2010
2	Rheumatoid FactorIBA 12/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2023 - 10/2003
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 07/2013
2	LDL CholesterolIBA 04/2022 - 07/2006
2	Triglycerides (Triacylglycerol)IBA 04/2022 - 01/2019
2	InterleukinsIBA 04/2022 - 11/2016
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2022 - 08/2011
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021 - 01/2020
2	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2020 - 12/2014
2	Calcium PyrophosphateIBA 08/2019 - 03/2013
2	ProcalcitoninIBA 08/2019 - 03/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2006

Therapy/Procedure

57	Therapeutics 12/2023 - 06/2002
8	Biological Therapy 02/2024 - 12/2005
4	Cryotherapy (Therapy, Cold) 11/2020 - 02/2014